Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease. - sprookjes - yvandenbroek - TriplyDB

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.

http://www.wikidata.org/entity/Q48266946

about

Neuropathology of non-Alzheimer degenerative disorders Neuropathological alterations in Alzheimer disease Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease.Alpha-synuclein and tau: teammates in neurodegeneration?Acyl-CoA synthetase activity links wild-type but not mutant alpha-synuclein to brain arachidonate metabolism Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease.Biophysics of Parkinson's disease: structure and aggregation of alpha-synuclein.Alpha-Synuclein contributes to GSK-3beta-catalyzed Tau phosphorylation in Parkinson's disease models.Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndrome Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.Neuropathology of synuclein aggregates.Alzheimer disease with amygdala Lewy bodies: a distinct form of alpha-synucleinopathy.Tau enhances α-synuclein aggregation and toxicity in cellular models of synucleinopathy.Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins.Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe.Parkinson's disease and other alpha-synucleinopathies.Lewy bodies.The cellular pathology of Parkinson's disease.The role of DYRK1A in neurodegenerative diseases.Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease.Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both Genetics of parkinsonism.Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains Familial Lewy body diseases.Effects of baseline CSF α-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer's disease.Alpha-synuclein levels in blood plasma decline with healthy aging.Molecular chaperones in Parkinson's disease--present and future Neurodegeneration with brain iron accumulation, type 1 is characterized by alpha-, beta-, and gamma-synuclein neuropathology.Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam Widespread nitration of pathological inclusions in neurodegenerative synucleinopathies Lewy body pathology in familial Alzheimer disease: evidence for disease- and mutation-specific pathologic phenotype Dementia with lewy bodies: molecular pathogenesis and implications for classification.Brain prostaglandin formation is increased by alpha-synuclein gene-ablation during global ischemia.α-Synuclein Amyloid Fibrils with Two Entwined, Asymmetrically Associated Protofibrils.An individualized approach to treatment for alzheimer's disease, pick's disease, and other dementias.Axon pathology in Parkinson's disease and Lewy body dementia hippocampus contains alpha-, beta-, and gamma-synuclein.Distinguishing Lewy body dementias from Alzheimer's disease.α-Synuclein in cerebrospinal fluid of Alzheimer's disease and mild cognitive impairment Physiological and pathological role of alpha-synuclein in Parkinson's disease through iron mediated oxidative stress; the role of a putative iron-responsive element

P2860

Q24657571-9529BD8B-347E-423F-BA6C-497216DDE823 Q27003314-30CEC724-FC62-4C5C-A53A-171E9EEB5DA8 Q27322563-715DFAB5-A2F5-48DD-A560-C3B59BC84237 Q28250508-9A878CEF-9E1C-48E1-9E2C-6F86C72B77B2 Q28586519-23A94564-872F-4321-8C61-6E11798795D7 Q30577687-3A1D1770-464D-4FBA-94FC-CC615D9AEACB Q33470625-F6C2C9F6-D0DC-42D3-9E90-C821B04B4267 Q33552220-301E772C-558E-4CF2-BC84-5CEFFA5319DB Q33830061-D48E3F32-FF98-4AB1-8C69-CEB957EA36F6 Q33847578-DE673D53-0D92-47BA-8F12-5DBAB97E59E8 Q33947152-9B5DDC38-F05B-4E75-9841-F4A1B5FD3F8B Q33957376-6C1AB115-F7B7-42FC-86DF-E28F2C6F85C6 Q33997481-59579379-93E9-4066-8752-3BB582CB5C26 Q34062509-AB8BB42B-089C-4B76-A321-7FE69FC36476 Q34111411-450803CA-05CF-49E7-9F33-4591160211C3 Q34114062-A4A8E591-D248-4566-A011-962B7FB76485 Q34270992-5E093A54-94CC-4F88-9E2A-C1383A73EF47 Q34478663-4661D954-FABE-4421-BDEB-EB7FD87F7E5F Q34523836-95928933-FBA1-4F00-9593-53C54BF0EE99 Q34642120-69B63DED-87AF-444E-918E-50AEDD433167 Q34709035-ACF599E9-B16B-4112-B400-FF78C8C06E44 Q34806323-E355F904-326F-4FDF-A54D-C19B689A2A80 Q34811944-DBE1CEFD-1DC8-4263-A22F-D334E2D7F163 Q35009550-325B2F21-61E5-4BA8-97C8-113B9F9327C5 Q35029476-5FFE6E96-CFC0-402C-BBF4-EA59770AD7FC Q35083125-5B0468DE-350B-4777-8A79-4E16ABA7B9B1 Q35284843-578694CC-E990-43F4-800B-C228BFADBC13 Q35688796-DBD2149D-D23A-4D62-A71B-45E80BFC1EED Q35745646-0DDECDFD-866D-427E-BCF4-FE1503FF84FE Q35748075-10B75E82-0CA0-44DA-9298-66E6612A1CF6 Q35829548-60EC54AA-AA7A-42F0-B5B1-255B78833D39 Q35843937-458236A4-2CA0-49D0-9D5D-2526F5C01048 Q35863395-6176D86D-673E-4652-B3DF-6847565FFE2F Q36507462-3A497B4E-C5EC-440F-85C2-2D5487153244 Q36518311-69C62657-71F0-4774-9B1A-F841B454F7AA Q36633738-E3BF3131-2CE3-489C-A824-8007D8078584 Q36677512-11989B5F-8E25-4DF9-AE65-F678551CC4DE Q36998833-E17BA64D-47A7-43FE-BBEB-4CC6365B3035 Q37086400-843128C0-4AE0-42AB-815C-69D81F231220 Q37166339-A8C50DBC-CC00-4BA5-9D0C-B7CC1E174E5C

P2860

Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease.

http://www.wikidata.org/entity/Q48266946

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh-hant

name

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@en

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@nl

type

label

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@en

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@nl

prefLabel

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@en

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@nl

P1433

Q48266946-9CE6F0AA-644D-4A6D-9FB8-C66D45E57E20

P1476

Q48266946-AE4F0B11-1598-4546-8499-E6B77E82376F

P2093

Q48266946-09E09679-EA20-41C5-B10E-4C116281CD35

Q48266946-5E625794-FEA6-4520-A7C3-EC228C4CBA27

Q48266946-8CE3F96F-8DBB-4E1F-85EF-FC6611D6F069

Q48266946-EE8BBE6E-ED2E-41AB-BA30-FE4A0D73312F

P2860

Q48266946-06356D2E-B12B-4708-A788-9972EE694695

Q48266946-09C8D914-3B91-43D3-B727-00A09C5E5B5E

Q48266946-0E923CFC-BD49-4212-8948-E3AB8E8D7418

Q48266946-1DE305AD-B747-4E87-B451-40271BC06388

Q48266946-23CE0A05-32B3-4D4C-B566-5D1A7BCB7FA6

Q48266946-441FC27F-35A0-4766-8B6E-1746C248964E

Q48266946-53D0B511-D5D2-409C-846C-2A03EF657707

Q48266946-5B03BF43-FBD0-4C0B-A899-19AAD42083AB

Q48266946-5FA5E22E-2CF6-4834-AE07-5CE0958F5506

Q48266946-68176CD0-C312-46C1-A5DC-A9B254B4568B

P304

Q48266946-09B75845-0BD3-476C-9E00-85C44D98CF41

P31

Q48266946-75F8B600-EFE7-4A25-A426-1C8CFA6FB52A

P356

Q48266946-40C93FAC-3116-4C80-9BED-0EEE110E4BDB

P433

Q48266946-FBE68DC3-7E7E-43E2-80C9-4A3B2A33140A

P478

Q48266946-BD04491A-79D6-4948-A173-1A3E88D5904A

P577

Q48266946-0915D952-8F3F-4E68-9CF6-B94A0AD3BB40

P698

Q48266946-73868A03-7266-4EB1-AD75-409E5E672AD7

P921

Q48266946-813BBE9F-7699-4606-9B0C-22BD54903F25

Q48266946-BE2AF5D6-2A36-42AE-B534-51528DF5FC0F

Q48266946-FEB3A2D2-AFFB-4770-BEC9-26BF4D13C824

P356

1531-8249(199903)45:3%3C353::AID-ANA11%3E3.0.CO;2-4

P1433

Annals of Neurology

P1476

Antibodies to alpha-synuclein ...... ains with Alzheimer's disease.

@en

P2093

Lee VM

http://www.w3.org/2001/XMLSchema#string

Lippa CF

http://www.w3.org/2001/XMLSchema#string

Schmidt ML

http://www.w3.org/2001/XMLSchema#string

Trojanowski JQ

http://www.w3.org/2001/XMLSchema#string

P2860

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease

A pathological study of the association between Lewy body disease and Alzheimer's disease.

Convergence of Lewy bodies and neurofibrillary tangles in amygdala neurons of Alzheimer's disease and Lewy body disorders.

Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes.

Diffuse Lewy body disease in Japan.

Staging of Alzheimer's disease-related neurofibrillary changes.

Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease.

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity.

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.

P304

353-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

1999-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10072050

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease